Hsu C. Eric's most recent trade in InMed Pharmaceuticals Inc was a trade of 13,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| InMed Pharma Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 13,000 | 18,280 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharma Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | 15 Dec 2025 | 70 | 5,280 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharma Inc | Hsu Eric C. | Sr. VP, Pre-Clinical Res/Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 2,750 | 5,350 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharma Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | 27 May 2024 | 545 | 52,000 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharma Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | 04 Mar 2024 | 309 | 52,545 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharma Inc | Hsu C. Eric | Sr. VP, Pre-Clinical Res/Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2023 | 45,000 | 52,854 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharma Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | 31 Aug 2023 | 327 | 7,854 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharma Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | 16 May 2023 | 152 | 8,181 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharma Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | 08 Mar 2023 | 545 | 8,333 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharma Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 4,200 | 8,878 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharma Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 4,200 | 8,878 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharma Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2021 | 35,000 | 116,969 | - | - | Employee Stock Option (Right to Buy) |